Carl Icahn is making a new bid to buy Mylan Laboratories, this time offering more than $5 billion for the drug company. He made his first bid for Mylan last fall as he fought against a proposed buyout of King Pharmaceutical. That deal fell apart earlier this year.
- read this story from the Boston Globe for more on the buyout offer